Medicare Rx: REALITY: MEDICARE MAY NEED TO SET SOME Rx PRICES
Health economist Joseph Newhouse predicts that the Medicare prescription-drug law's "non-interference clause," which prohibits the federal government from using its clout to achieve lower drug prices, is unlikely to last long.
The language - for which pharmaceutical manufacturers fought hard - "will be modified at some point," said the Harvard University economist and Medicare Payment Advisory Commission member at a Jan. 8 forum sponsored by Health Affairs.
For most drugs, the law sets up a market-pricing system that likely will persist, says Newhouse. Most drugs have either generic or other brand-name competitors, and for those products, private...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: